Jul 01, 2020
While Gilead/Galapagos' Filgotinib Will Have to Contend with the Early Success of AbbVie's Rinvoq in the US Rheumatoid Arthritis Market, Eli Lilly's Olumiant is Likely to be the More Formidable Foe in the EU
Jun 08, 2020
Lilly to Participate in Goldman Sachs Global Healthcare Conference
Jun 08, 2020
Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment
Jun 01, 2020
Lilly Begins World's First Study of a Potential COVID-19 Antibody Treatment in Humans
May 31, 2020
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma
May 26, 2020
Statement from Lilly Chairman and CEO Dave Ricks on New Part D Senior Savings Model
May 04, 2020
Lilly Declares Second-Quarter 2020 Dividend
May 04, 2020
Lilly and Junshi Biosciences to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19
Apr 30, 2020
Lilly to Participate in Bank of America Securities Health Care Conference
Apr 08, 2020
Lilly Confirms Date and Conference Call for First-Quarter 2020 Financial Results Announcement
Apr 07, 2020
Eli Lilly and Company to Hold 2020 Annual Meeting of Shareholders Virtually
Mar 31, 2020
Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines
Mar 24, 2020
Updates from Lilly about insulin supply and affordability
Mar 23, 2020
Lilly Provides Update on Clinical Trial Activities During COVID-19 Pandemic
Mar 22, 2020
Lilly to Provide Drive-Through COVID-19 Testing for Indianapolis Health Care Workers
Mar 20, 2020
Kathryn Beiser to join Lilly as Vice President, Global Communications
Mar 20, 2020
US FDA issues complete response letter for empagliflozin 2.5 mg as adjunct to insulin for adults with type 1 diabetes
Mar 18, 2020
Lilly, Indiana State Department of Health Partner to Accelerate COVID-19 Testing Using Lilly Research Laboratories
Mar 12, 2020
AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19
Mar 09, 2020
Lilly to Participate in Barclays Global Healthcare Conference